Drug Type Small molecule drug |
Synonyms SYHA 1807, SYHA-1807 |
Target |
Action inhibitors |
Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Phase 1 | China | 14 Jun 2023 | |
Extensive stage Small Cell Lung Cancer | Phase 1 | - | 01 Jun 2020 |